Using cell therapy to treat primary open angle glaucoma
Translational Studies toward Cell Therapy for Treatment of Primary Open Angle Glaucoma
This study is testing a new cell therapy to help people with primary open angle glaucoma by using special stem cells to improve eye function and lower pressure, which could help prevent vision loss when regular treatments aren't enough.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa City VA Medical Center NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10995780 on NIH RePORTER |
What this research studies
This research focuses on developing a novel cell therapy aimed at treating primary open angle glaucoma (POAG), a condition that can lead to blindness. The approach involves using induced pluripotent stem cells (iPSC) that can be transformed into cells resembling those in the trabecular meshwork, which is crucial for regulating intraocular pressure (IOP). By transplanting these cells into the eyes of mouse models, the researchers aim to restore the function of the trabecular meshwork, reduce IOP, and prevent vision loss. This innovative method seeks to provide a long-term solution for patients who struggle with traditional glaucoma treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with primary open angle glaucoma, particularly those who have not responded well to conventional treatments.
Not a fit: Patients with other forms of glaucoma or those who do not have a diagnosis of primary open angle glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment that restores vision and improves quality of life for patients with glaucoma.
How similar studies have performed: Previous studies have shown promise in using cell therapy for glaucoma treatment, indicating that this approach has potential based on early successes.
Where this research is happening
Iowa City, United States
- Iowa City VA Medical Center — Iowa City, United States (Active)
Researchers
- Principal investigator: Kuehn, Markus H. — Iowa City VA Medical Center
- Study coordinator: Kuehn, Markus H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.